162 related articles for article (PubMed ID: 1999047)
21. Reperfusion-induced arrhythmias: a study of the role of xanthine oxidase-derived free radicals in the rat heart.
Manning A; Bernier M; Crome R; Little S; Hearse D
J Mol Cell Cardiol; 1988 Jan; 20(1):35-45. PubMed ID: 3367377
[TBL] [Abstract][Full Text] [Related]
22. Prevention of reperfusion injury in ischemic-reperfused hearts by oxypurinol and allopurinol.
LoBalsamo L; Bergsland J; Lajos P; Feldman MJ
Transpl Int; 1989 Dec; 2(4):218-22. PubMed ID: 2627264
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
24. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
25. [Effect of xanthine oxidase inhibitors on the prognosis of acute intestinal ischemia].
Holgado Madruga M; Refoyo Enríquez A; Mariño Hernández E; Martín Rollán C; García García J; Macías Núñez JF
An Med Interna; 1989 Apr; 6(4):177-82. PubMed ID: 2562372
[TBL] [Abstract][Full Text] [Related]
26. Effect of oxypurinol on renal reperfusion injury in the rat.
Dillon JJ; Grossman SH; Finn WF
Ren Fail; 1993; 15(1):37-45. PubMed ID: 8441835
[TBL] [Abstract][Full Text] [Related]
27. Superoxide radical production by allopurinol and xanthine oxidase.
Galbusera C; Orth P; Fedida D; Spector T
Biochem Pharmacol; 2006 Jun; 71(12):1747-52. PubMed ID: 16650385
[TBL] [Abstract][Full Text] [Related]
28. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals.
Hoey BM; Butler J; Halliwell B
Free Radic Res Commun; 1988; 4(4):259-63. PubMed ID: 2852627
[TBL] [Abstract][Full Text] [Related]
29. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest.
Chambers DJ; Braimbridge MV; Hearse DJ
Ann Thorac Surg; 1987 Sep; 44(3):291-7. PubMed ID: 3632115
[TBL] [Abstract][Full Text] [Related]
30. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
[TBL] [Abstract][Full Text] [Related]
31. Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury.
Werns SW; Lucchesi BR
Cardiovasc Drugs Ther; 1989 Jan; 2(6):761-9. PubMed ID: 2488090
[TBL] [Abstract][Full Text] [Related]
32. Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion?
Hearse DJ; Manning AS; Downey JM; Yellon DM
Acta Physiol Scand Suppl; 1986; 548():65-78. PubMed ID: 3529823
[TBL] [Abstract][Full Text] [Related]
33. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
[TBL] [Abstract][Full Text] [Related]
34. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Yao Z; Gross GJ
Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
[TBL] [Abstract][Full Text] [Related]
35. Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
Hopson SB; Lust RM; Sun YS; Zeri RS; Morrison RF; Otaki M; Chitwood WR
J Natl Med Assoc; 1995 Jul; 87(7):480-4. PubMed ID: 7636893
[TBL] [Abstract][Full Text] [Related]
36. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species.
Goto M; Miura T; Iliodoromitis EK; O'Leary EL; Ishimoto R; Yellon DM; Iimura O
Cardiovasc Res; 1991 Nov; 25(11):943-9. PubMed ID: 1813123
[TBL] [Abstract][Full Text] [Related]
37. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Doherty NE; Brunsting LA; Wechsler AS
Circulation; 1988 Nov; 78(5 Pt 2):III224-35. PubMed ID: 3180402
[TBL] [Abstract][Full Text] [Related]
38. Combined adenosine and lidocaine administration limits myocardial reperfusion injury.
Homeister JW; Hoff PT; Fletcher DD; Lucchesi BR
Circulation; 1990 Aug; 82(2):595-608. PubMed ID: 2372906
[TBL] [Abstract][Full Text] [Related]
39. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
40. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.
Simpson PJ; Todd RF; Mickelson JK; Fantone JC; Gallagher KP; Lee KA; Tamura Y; Cronin M; Lucchesi BR
Circulation; 1990 Jan; 81(1):226-37. PubMed ID: 2153476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
